Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
M. J. Rico, H. A. Perroud, L. E. Mainetti, V. R. Rozados & O. G. Scharovsky. (2014) Comparative Effectiveness of Two Metronomic Chemotherapy Schedules—Our Experience in the Preclinical Field. Cancer Investigation 32:3, pages 92-98.
Read now
Read now
Articles from other publishers (7)
Marina T Van Leeuwen, Steven Luu, Howard Gurney, Martin R Brown, Sallie-Anne Pearson, Kate Webber, Lee Hunt, Soojung Hong, Geoffrey P Delaney & Claire M Vajdic. (2020) Cardiovascular Toxicity of Targeted Therapies for Cancer: An Overview of Systematic Reviews. JNCI Cancer Spectrum 4:6.
Crossref
Crossref
Bao-jie Xie, Li-na Zhu, Can Ma, Ji-bin Li, Lei Dong, Zhong-ning Zhu, Tao Ding & Xin-shun Gu. (2019) A network meta-analysis on the efficacy of HER2-targeted agents in combination with taxane-containing regimens for treatment of HER2-positive metastatic breast cancer. Breast Cancer 27:2, pages 186-196.
Crossref
Crossref
Daniela Laudisio, Giovanna Muscogiuri, Luigi Barrea, Silvia Savastano & Annamaria Colao. (2018) Obesity and breast cancer in premenopausal women: Current evidence and future perspectives. European Journal of Obstetrics & Gynecology and Reproductive Biology 230, pages 217-221.
Crossref
Crossref
Ralf-Dieter Hofheinz, Siegfried Segaert, María José Safont, Gaston Demonty & Hans Prenen. (2017) Management of adverse events during treatment of gastrointestinal cancers with epidermal growth factor inhibitors. Critical Reviews in Oncology/Hematology 114, pages 102-113.
Crossref
Crossref
Paulo Michel Pinheiro Ferreira & Cláudia Pessoa. (2017) Molecular biology of human epidermal receptors, signaling pathways and targeted therapy against cancers: new evidences and old challenges. Brazilian Journal of Pharmaceutical Sciences 53:2.
Crossref
Crossref
Qiuyan Yu, Zhenli Zhu, Yan Liu, Jun Zhang & Ke Li. (2015) Efficacy and Safety of HER2-Targeted Agents for Breast Cancer with HER2-Overexpression: A Network Meta-Analysis. PLOS ONE 10:5, pages e0127404.
Crossref
Crossref
Huiyuan Wang, Feng Li, Chengan Du, Huixin Wang, Ram I. Mahato & Yongzhuo Huang. (2014) Doxorubicin and Lapatinib Combination Nanomedicine for Treating Resistant Breast Cancer. Molecular Pharmaceutics 11:8, pages 2600-2611.
Crossref
Crossref